Concert Pharmaceuticals, Inc. Proceeds from Long-Term Debt Issued
Concert Pharmaceuticals, Inc. reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2019-02-28
- Concert Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $0.00.
- Concert Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2017-12-31 was $0.00.
- Concert Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Concert Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2017 was $29.66M.
- Concert Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2016 was $0.00.
- Concert Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2012 was $12.50M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $29.66M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $29.66M 10-Q · filed 2018-11-01 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 | ||
| 2012-12-31 | $12.50M 10-K · filed 2015-03-02 |